Skip to NavigationSkip to content


AstraZeneca lung cancer drug Iressa has gained US approval after an extended review found the drug to be safe, despite cases of serious and sometimes...
GlaxoSmithKline is to drop claims on patient information leaflets that its antidepressant Seroxat is not addictive.
Generic competition to Losec limited AstraZeneca sales growth in the first quarter although strong growth of other products has indicated underlying...
The Government's controversial plans to introduce foundation hospitals are on a knife-edge ahead of a Commons vote on the reform next week.
Shares in UK vaccines specialist PowderJect rose nearly 8% after it confirmed an unnamed company had made a buyout offer.
GlaxoSmithKline has posted 11% growth in the first quarter of 2003 despite generic competition for its blockbuster antibiotic Augmentin.
OTC omeprazole to become Glaxo's next generation Zantac
Sanofi-Synthelabo has upgraded its full-year share earnings guidance for 2003, despite its plans to spend more on R&D.
Doctors and health unions have expressed their concerns about the effect of new fast track surgery centres on the rest of the NHS.
Mission Statement is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches